The underwriters of an initial public offering of Isolagen Inc. stock have asked a judge to reconsider a previous decision to not dismiss them from a proposed securities class action lawsuit.
Toyko-based drug company Eisai Co. Ltd. has reached a sort of detente with generic drugmakers Mutual Pharmaceuticals Company, Inc. and United Research Laboratories Inc. in a patent dispute over the billion-dollar Alzheimer's treatment Aricept.
Drug maker Wyeth Pharmaceuticals Inc. has lost a third trial over its controversial hormone replacement treatment, with a Nevada jury on Wednesday awarding $134.5 million to three women who blamed the drug for their breast cancer.
In a blow to a group of Aredia and Zometa plaintiffs, the judge overseeing the product liability suit involving the bone cancer drugs has rejected calls for the establishment of a dental monitoring class in the multidistrict litigation against Novartis Pharmaceuticals Corp.
In another bid for damage control in the stent suit Boston Scientific Corp. filed against it five years ago, Johnson & Johnson subsidiary Cordis Corp. has asked for judgment as a matter of law on the suit's claims of willful infringement of three patents.
Mega conglomerate General Electric Co. has been hit with yet another lawsuit over its injectable contrast agent, Omniscan, this time by a Missouri man who claims the toxic dye caused an incurable and debilitating disease.
Barr Laboratories has fired back at Celgene Corp. in a patent suit over the market for Celgene's cancer treatment Thalomid, alleging that Celgene's patents are invalid and accusing Celgene of violating the Sherman Act by impeding Barr's efforts to market generic thalidomide.
The judge overseeing the litigation over bladder control drug Ditropan XL has again tossed a direct purchaser suit against two Johnson & Johnson subsidiaries he said the plaintiff didn't have standing to sue, leaving one now ousted for good and another suable for just three more weeks.
A federal judge has combined a number of product liability suits over Organon International Inc.'s contraceptive device NuvaRing for the purpose of deciding whether they should be remanded to state court.
Apotex Inc.'s third trip to the Federal Circuit in its long-running patent spat with Abbott Laboratories over the epilepsy drug Depakote on Thursday yielded a reversal of a lower court’s ruling that had found the generics maker in contempt of an earlier injunction.
German competition regulators have raided the offices of Bayer AG, looking for evidence to support the claim that the drug maker attempted to fix the price of aspirin.
In a blow to a Novartis AG subsidiary, the U.S. Patent and Trademark Office has issued a final interference decision striking down a patent covering technology for detecting HIV in the blood.
California Gov. Arnold Schwarzenegger released revised details of his statewide health care reform bill on Tuesday and proposed using the California lottery to help pay the tab.
A doctor from New Jersey is suing Johnson & Johnson and subsidiary Cordis Corp. in a bid to tap into the multibillion-dollar market for drug-eluting coronary stents, claiming that the defendants' stents infringe a patent he secured in 1997.
The Federal Trade Commission has targeted the makers of an infomercial for allegedly deceiving consumers by promoting a weight loss book that claims to be “easy” but relies on severe dieting restrictions and daily injections of a drug that has not been approved for weight loss by the Food and Drug Administration.
Merck and the patients who sued over its bone drug Fosamax are sparring over who should fund discovery requests in the multidistrict litigation.
Boston Scientific Corp. has put up a fight against a motion by two plaintiffs to remove their product liability lawsuit over faulty implantable heart defibrillators to state court, taking aim at their argument that Guidant Corp. is no longer a defendant.
A former employee of Amerigroup Corp. has accused the health-insurance and managed-care provider of failing to pay the elevated overtime wages required by federal law.
A unit of pharmaceutical giant Johnson & Johnson has sued Hologic, alleging that the Massachusetts health company infringed on numerous patents that cover surgical systems used primarily in breast cancer biopsies.
Drug maker Eli Lilly and Co. has decided to put stronger product labels on its blockbuster antipsychotic treatment Zyprexa, adding new warnings about the potential for weight gain and elevated blood sugar or cholesterol levels.